Antag (private company)

See something wrong or missing? Let us know
Offices:
Copenhagen
Business model:
B2B B2C (Retail)
Investors:
Novo Seeds

Total investments received (USD) - 3M

  • Jun 2017 -
    3M

Antag has developed a novel anti-obesity treatment based on a highly potent inhibitor of a hormone involved in fat accumulation.

Companies with similar profile to Antag:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

News about Antag (1)